<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><?origin nihpa?><?iso-abbr Nat. Immunol.?><?submitter-system nihms?><?submitter-canonical-name Nature Publishing Group?><?submitter-canonical-id NATURE-STRUCTUR?><?submitter-userid 8068858?><?submitter-authority myNCBI?><?submitter-login nature-structure?><?submitter-name Nature Publishing Group?><?domain nihpa?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">100941354</journal-id><journal-id journal-id-type="pubmed-jr-id">21750</journal-id><journal-id journal-id-type="nlm-ta">Nat Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Nat. Immunol.</journal-id><journal-title-group><journal-title>Nature immunology</journal-title></journal-title-group><issn pub-type="ppub">1529-2908</issn><issn pub-type="epub">1529-2916</issn></journal-meta><article-meta><article-id pub-id-type="pmcid">4955715</article-id><article-id pub-id-type="pmid">27270402</article-id><article-id pub-id-type="doi">10.1038/ni.3483</article-id><article-id pub-id-type="manuscript">nihpa784701</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Human memory T cells with a na&#x000ef;ve phenotype accumulate with aging and respond to persistent viruses</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pulko</surname><given-names>Vesna</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Davies</surname><given-names>John S.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Martinez</surname><given-names>Carmine</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lanteri</surname><given-names>Marion C.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Busch</surname><given-names>Michael P.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Diamond</surname><given-names>Michael S.</given-names></name><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Knox</surname><given-names>Kenneth</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Busch</surname><given-names>Erin S.</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>Sims</surname><given-names>Peter A.</given-names></name><xref ref-type="aff" rid="A8">8</xref><xref ref-type="aff" rid="A9">9</xref><xref ref-type="aff" rid="A10">10</xref></contrib><contrib contrib-type="author"><name><surname>Sinari</surname><given-names>Shripad</given-names></name><xref ref-type="aff" rid="A11">11</xref></contrib><contrib contrib-type="author"><name><surname>Billheimer</surname><given-names>Dean</given-names></name><xref ref-type="aff" rid="A11">11</xref></contrib><contrib contrib-type="author"><name><surname>Haddad</surname><given-names>Elias K.</given-names></name><xref ref-type="aff" rid="A12">12</xref></contrib><contrib contrib-type="author"><name><surname>Murray</surname><given-names>Kristy O.</given-names></name><xref ref-type="aff" rid="A13">13</xref><xref ref-type="aff" rid="A14">14</xref><xref ref-type="aff" rid="A15">15</xref></contrib><contrib contrib-type="author"><name><surname>Wertheimer</surname><given-names>Anne M.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Nikolich-&#x0017d;ugich</surname><given-names>Janko</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A7">7</xref><xref rid="FN1" ref-type="author-notes">#</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ</aff><aff id="A2"><label>2</label>Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ</aff><aff id="A3"><label>3</label>Blood Systems Research Institute, San Francisco, CA</aff><aff id="A4"><label>4</label>Department of Medicine, Washington University, St. Louis, MO</aff><aff id="A5"><label>5</label>Department of Molecular Microbiology, Washington University, St. Louis, MO</aff><aff id="A6"><label>6</label>Department of Pathology and Immunology, Washington University, St. Louis, MO</aff><aff id="A7"><label>7</label>Department of Medicine, University of Arizona College of Medicine, Tucson, AZ</aff><aff id="A8"><label>8</label>Department of Systems Biology, Columbia University Medical Center, New York, NY</aff><aff id="A9"><label>9</label>Department of Biochemistry &#x00026; Molecular Biophysics, Columbia University Medical Center, New York, NY</aff><aff id="A10"><label>10</label>Sulzburger Columbia Genome Center, Columbia University Medical Center, New York, NY</aff><aff id="A11"><label>11</label>Statistics Consulting Laboratory, Bio5, University of Arizona, Tucson AZ</aff><aff id="A12"><label>12</label>Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA</aff><aff id="A13"><label>13</label>Department of Pediatrics, Baylor College of Medicine, Houston, TX</aff><aff id="A14"><label>14</label>National School of Tropical Medicine, Baylor College of Medicine, Houston, TX</aff><aff id="A15"><label>15</label>Texas Children&#x02019;s Hospital, Houston, TX</aff><author-notes><corresp id="FN1"><label>#</label>to whom correspondence should be addressed at <email>Nikolich@email.arizona.edu</email>, or at Box 245221, 1501 N. Campbell Ave, Tucson, AZ, 85724, USA</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>11</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>06</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>06</day><month>12</month><year>2016</year></pub-date><volume>17</volume><issue>8</issue><fpage>966</fpage><lpage>975</lpage><!--elocation-id from pubmed: 10.1038/ni.3483--><permissions><license><license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
<uri xlink:type="simple" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p></license></permissions><abstract><p id="P1">The numbers of naive T cells decrease, and the susceptibility to new microbial infections increases with age. Here, we describe a new subset of phenotypically naive human CD8<sup>+</sup>T cells that rapidly secrete multiple cytokines in response to persistent viral antigens but differ transcriptionally from memory and effector T cells. The frequency of these CD8<sup>+</sup>T cells, named T memory cells with na&#x000ef;ve phenotype (T<sub>MNP</sub>) increased with age and following severe acute infection and inversely correlated with the residual immune capacity to respond to new infections with age. CD8<sup>+</sup>T<sub>MNP</sub> cells represent a new potential target for immunotherapy of persistent infections, and should be accounted for and subtracted from the naive pool if truly naive T cells are needed to respond to antigens.</p></abstract></article-meta></front><body><p id="P2">Protective immunity against new infections requires sufficient numbers and diversity of naive T lymphocytes (T<bold><sub>N</sub></bold>), with strong expansion and effector differentiation potential<sup><xref rid="R1" ref-type="bibr">1</xref></sup>. With aging, the human T<sub>N</sub> cell pool shrinks<sup><xref rid="R2" ref-type="bibr">2</xref></sup> and may or may not lose diversity<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup>; and old T<sub>N</sub> cells exhibit proliferation and effector differentiation defects<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup>. This likely precipitates the vulnerability of older adults to new and re-emerging infections, such as influenza, West Nile virus (WNV), etc. and limits the efficacy of vaccination against infectious diseases<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup>.</p><p id="P3">Drivers contributing to age-related decline in T<sub>N</sub> cell homeostasis and function, include thymic involution<sup><xref rid="R11" ref-type="bibr">11</xref></sup>, impaired peripheral T cell maintenance<sup><xref rid="R12" ref-type="bibr">12</xref></sup>, &#x0201c;homeostatic&#x0201d; conversion to memory phenotype(s)<sup><xref rid="R12" ref-type="bibr">12</xref></sup> and repeated antigen exposure due to persistent infections<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup>. However, the extent of quantitative and quantitative age-related decline in T<sub>N</sub> function and homeostasis remains incompletely understood.</p><p id="P4">T cell phenotype has long been used as means to functionally classify T cell subsets (rev. in<sup><xref rid="R14" ref-type="bibr">14</xref></sup>). For example, naive T cells (T<sub>N</sub>) cells exhibit no immediate effector functions<sup><xref rid="R14" ref-type="bibr">14</xref></sup>, whereas T effector + effector memory (T<sub>E+EM</sub>), T effector memory cells reexpressing CD45RA (T<sub>EMRA</sub>), and to a lesser extent central memory cells (T<sub>CM</sub>,) cells can rapidly express multiple different effector molecules (cytokines and cytotoxic molecules such as granzymes &#x02013;Gzm, and perforin) upon antigen stimulation, to enable rapid control of reinfection. T<sub>CM</sub>, which are less polyfunctional, primarily reside in secondary lymphoid organs and maintain high proliferative potential<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup>. T memory (T<sub>M</sub>) and T<sub>N</sub> cells are maintained by interleukin 7(IL-7) and IL-15, respectively<sup><xref rid="R17" ref-type="bibr">17</xref></sup>.</p><p id="P5">While testing human T cell function across aging, we discovered a subset of phenotypically T<sub>N</sub> cells capable of producing effector cytokines immediately upon T cell receptor (TCR) stimulation. These memory T cells with na&#x000ef;ve phenotype (which we refer to as T<sub>MNP</sub>) were dominantly CD8<sup>+</sup>, exhibited a transcriptome distinct from other T cell subsets and increased in frequency with age. T<sub>MNP</sub> cells responded to antigens from persistent viruses. They were expanded in patients who experienced symptomatic, but not asymptomatic, WNV infection, months and years following infection, and were the only T cell subset (including T<sub>N</sub>, T<sub>CM</sub>, T<sub>EM</sub>, and T<sub>EMRA</sub>) that correlated with symptomatic WNV infection. Therefore, the presence of CD8<sup>+</sup>T<sub>MNP</sub> cells could be useful in immunotherapy of persistent infections, or should be accounted for if truly naive T cells are needed to respond to antigens.</p><sec sec-type="results" id="S1"><title>RESULTS</title><sec id="S2"><title>A subset of phenotypically naive T cells produce cytokines</title><p id="P6">One key age-related population change in the T cell pool is an absolute numerical decrease of blood CD8<sup>+</sup>T<sub>N</sub> cells<sup><xref rid="R2" ref-type="bibr">2</xref></sup>. To investigate whether the peripheral blood CD8<sup>+</sup>T<sub>N</sub> cells also show qualitatively altered responses with aging, we stimulated peripheral blood mononuclear cells (PBMC, used throughout the study, unless otherwise specified) from 92 subjects (43 males, 49 females, aged 21&#x02013;97y) with phorbol-myristate acetate (PMA) and calcium ionophore ionomycin(Iono) for 3h and measured intracellular interferon-&#x003b3; (IFN-&#x003b3;) cytokine protein production (<xref rid="F1" ref-type="fig">Fig. 1</xref>). Multicolor flow cytometry (FCM) was performed to gate on the four main CD8<sup>+</sup> T cell subsets (T<sub>N</sub>, T<sub>CM</sub>, T<sub>EM</sub>, and T<sub>EMRA</sub>) defined by CD45RA, CCR7, CD95 and CD28 Thereby, T<sub>N</sub> cells were classified as CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>low</sup>CD28<sup>int</sup>; T<sub>CM</sub> as CD45RA<sup>&#x02212;</sup>CCR7<sup>+</sup>CD95<sup>hi</sup>CD28<sup>hi</sup>T<sub>E+EM</sub> as CD45RA<sup>&#x02212;</sup>CCR7<sup>&#x02212;</sup>CD95<sup>hi</sup>CD28<sup>low</sup> and T<sub>EMRA</sub> as CD45RA<sup>+</sup>CCR7<sup>&#x02212;</sup> CD95<sup>hi</sup>CD28<sup>low.</sup>. These definitions were used throughout this study (unless indicated, where full phenotype is provided), because they correlate well with the functional characteristics of different T cell subsets. and in<sup><xref rid="R14" ref-type="bibr">14</xref></sup> (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 1a,b</xref>). Total CD8<sup>+</sup>T<sub>N</sub> numbers declined with aging from &#x0003e;250 cells/&#x003bc;l blood at 20&#x02013;30y to &#x0003c;50 cells/&#x003bc;l at &#x0003e;80y of age (<xref rid="F1" ref-type="fig">Fig. 1a</xref>, <xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 1c</xref>), confirming previous observations<sup><xref rid="R2" ref-type="bibr">2</xref></sup>. However, following a 3h stimulation with PMA + Iono, 0.2&#x02013;50% of CD8<sup>+</sup> T<sub>N</sub> cells produced IFN-&#x003b3;, in comparison to &#x0003c;0.1% in unstimulated controls and &#x0003e;60% of T<sub>EM</sub> and T<sub>EMRA</sub> cells (<xref rid="F1" ref-type="fig">Fig. 1a</xref>). This fraction increased with age, from 2.9 &#x000b1;1.7% in 21&#x02013;40y olds, to 8.7&#x000b1;9.9% of CD8<sup>+</sup>T<sub>N</sub> cells in people &#x0003e;65 y (<xref rid="F1" ref-type="fig">Fig. 1b</xref>). The increase in IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup>T<sub>N</sub> cells with age was relative; their absolute number also declined with age, albeit less rapidly than the CD8<sup>+</sup>T<sub>N</sub> cells (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 1c</xref>). A fraction of PMA+Iono-stimulated CD4<sup>+</sup>T<sub>N</sub> cells (1&#x02013;2%) also produced IFN-&#x003b3; (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 1d</xref>). Upon PMA+Iono stimulation, freshly isolated PBMCs (n=7, 36&#x02013;76y) and sorted CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>hi</sup>CD28<sup>low</sup> CD8<sup>+</sup>T<sub>N</sub> cells (n=2, 40 and 69y, representative of n=6, 32&#x02013;76y) produced GzmB (0.06&#x02013;11.1%), IFN-&#x003b3; (0.5&#x02013;16.2%), IL-2 (0.4&#x02013;3.8%) and TNF (1.8&#x02013;22.7%); brefeldin A (BfA) background control was &#x0003c;0.37%) (<xref rid="F1" ref-type="fig">Fig. 1c</xref>; <xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 1d,e</xref>). This excluded the possibility that the IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup> cells were T<sub>M</sub> cells that acquired a naive phenotype during the freeze-thaw process or PMA+Iono stimulation. IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup>T<sub>N</sub> cells did not exhibit homogenous expression of CD45RA, CCR7, CD28 and CD95 and were dispersed within the T<sub>N</sub> gate (<xref rid="F1" ref-type="fig">Fig. 1a</xref>), showing phenotypic microheterogeneity like other T cell subsets<sup><xref rid="R18" ref-type="bibr">18</xref></sup>. This suggests that IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup>T<sub>N</sub> cells are not a contaminating memory population that clusters adjacent to T<sub>M</sub>. Thus, a subset of phenotypically CD8<sup>+</sup>T<sub>N</sub> cells can produce multiple cytokines upon polyclonal stimulation.</p></sec><sec id="S3"><title>T<sub>M</sub> cells with naive phenotype (T<sub>MNP</sub>) are CD49d<sup>+</sup>CXCR3<sup>+</sup></title><p id="P7">To assess whether the cytokine-producing CD8<sup>+</sup>T<sub>N</sub> cells can be distinguished from other T<sub>N</sub> cells we used SPADE (cyto-spanning-tree progression of density-normalized events), an unsupervised clustering FCM analysis software. The expression of five T cell activation and differentiation markers (CD45RA, CCR7, CD95, CD28 and CD45RO) distinguished four canonical T cell subsets (T<sub>N</sub>, T<sub>CM</sub>, T<sub>E/EM</sub>, and T<sub>EMRA</sub>) amongst the PMA+Iono-stimulated PBMC (<xref rid="F2" ref-type="fig">Fig. 2a,b</xref>). The T<sub>N</sub> cell subset was further split into seven nodes, four of which were T<sub>N</sub> by the CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>low</sup>CD28<sup>int</sup> phenotypic definition, and one of whom was enriched for IFN-&#x003b3;-producing cells (<xref rid="F2" ref-type="fig">Fig. 2a</xref>), suggesting that IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup>T<sub>N</sub> cells represent a distinct T cell subset.</p><p id="P8">When scoring the expression of a broader set of markers to stringently define CD8<sup>+</sup>T<sub>N</sub> cell as CD27<sup>+</sup>CD45RO<sup>&#x02212;</sup>CD127<sup>+</sup>CD122<sup>lo</sup>CD31<sup>+</sup>CD11a<sup>&#x02212;</sup>HLA-DR<sup>&#x02212;</sup>, IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup>T<sub>N</sub> cells did not diverge from IFN&#x003b3;<sup>&#x02212;</sup>CD8<sup>+</sup>T<sub>N</sub> cells, regardless of whether we initially gated through less (CD45RA<sup>+</sup> CCR7<sup>+</sup>) or more stringent (CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>low</sup>CD28<sup>int</sup>) T<sub>N</sub> gate (<xref rid="F3" ref-type="fig">Fig. 3</xref>, <xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 2a</xref>). However, mean fluorescence intensity (MFI) expression analysis revealed that IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup>T<sub>N</sub> cells expressed slightly less CCR7 and more CD28 compared to IFN-&#x003b3;<sup>&#x02212;</sup>CD8<sup>+</sup>T<sub>N</sub> cells; CD45RA and CD95 expression was similar (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 2b</xref>). The phenotypic profile of IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup> T<sub>N</sub> cells was markedly distinct from T<sub>CM</sub> and T<sub>E+EM</sub> cells (<xref rid="F3" ref-type="fig">Fig. 3b,c</xref>, <xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 2</xref>). The effector-memory function of IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup>T<sub>N</sub> cells, along with their naive phenotype, led us to name these cells as memory T cells with naive phenotype(T<sub>MNP</sub>). We next analyzed trafficking and adhesion receptors on T<sub>MNP</sub> cells. CD49d, the &#x003b1;<sub>4</sub> integrin, associates with &#x003b2; subunits to form &#x003b1;<sub>4</sub>&#x003b2;<sub>7</sub> or &#x003b1;<sub>4</sub>&#x003b2;<sub>1</sub> heterodimers that regulate effector-memory T cell trafficking<sup><xref rid="R19" ref-type="bibr">19</xref></sup>. In mice, CD49d exclusively marks antigen-experienced T<sub>M</sub> cells<sup><xref rid="R20" ref-type="bibr">20</xref></sup>. IFN-&#x003b3;<sup>+</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>low</sup>CD28<sup>int</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells consistently expressed the most CD49d compared to T<sub>N</sub>, T<sub>CM</sub>, T<sub>EM</sub>, and T<sub>EMRA</sub>, on average a 2.5-fold higher CD49d geometric MFI (gMFI) than the IFN-&#x003b3;<sup>&#x02212;</sup>CD8<sup>+</sup>T<sub>N</sub> cells (<xref rid="F3" ref-type="fig">Fig. 3c,d</xref>). However, while all IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells were CD49d<sup>hi</sup>, &#x0003c;10% CD49d<sup>hi</sup>CD8<sup>+</sup>T<sub>N</sub> cells did not produce IFN-&#x003b3;, suggesting that CD49d highly enriches, but not exclusively identify, CD8<sup>+</sup>T<sub>MNP</sub> cells. IFN-&#x003b3;<sup>+</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>low</sup>CD28<sup>int</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells also expressed the highest (p&#x0003c;0.0001 vs T<sub>N</sub> cells) levels of the chemokine receptor CXCR3 compared to T<sub>N</sub> (defined as IFN-&#x003b3;<sup>&#x02212;</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>low</sup>CD28<sup>int</sup>), T<sub>CM</sub>, T<sub>EM</sub>, and T<sub>EMRA</sub> (<xref rid="F3" ref-type="fig">Fig. 3c,d</xref>), suggesting the capacity to respond rapidly to CXCL9, CXCL10 and CXCL11, which would direct them to inflamed sites<sup><xref rid="R21" ref-type="bibr">21</xref></sup>. Because CD49d and CD103 (&#x003b1;<sub>E</sub> integrin) can both bind &#x003b2;7 integrin, and because CD103/&#x003b2;7 heterodimer directs immune cell trafficking to tissue residence, including gut mucosa<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup> we tested expression of CD103, which was comparably low on CD8<sup>+</sup>T<sub>MNP</sub> and CD8<sup>+</sup>T<sub>N</sub> cells (<xref rid="F3" ref-type="fig">Fig. 3c</xref>), suggesting that these cells are unlikely to home to gut mucosa. Therefore, while CD8<sup>+</sup>T<sub>MNP</sub> cells possess most of the CD8<sup>+</sup>T<sub>N</sub> phenotypic attributes, they exhibit rapid functional responses and have the potential to traffic to inflamed sites.</p></sec><sec id="S4"><title>T<sub>MNP</sub> cells are preactivated due to Erk phosphorylation</title><p id="P9">To determine whether CD8<sup>+</sup>T<sub>MNP</sub> cells respond to TCR-mediated activation, we stimulated PBMC (n=5, 33&#x02013;77y) for 3h with plate-bound anti-CD3, and soluble anti-CD28 &#x000b1;anti-CD49d Ab. TCR crosslinking induced production of IFN-&#x003b3;, TNF and GzmB in CD49d<sup>hi</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>low</sup>CD28<sup>int</sup> CD8<sup>+</sup>T<sub>MNP</sub> cells, although the frequency of IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells was 20&#x02013;30% of that induced by PMA+Iono (<xref rid="F4" ref-type="fig">Fig. 4a</xref>). Anti-CD49d antibodies did not affect the magnitude (<xref rid="F4" ref-type="fig">Fig. 4a</xref>), breadth or kinetics of cytokine production (not shown). Therefore, CD49d engagement does not costimulate production of IFN-&#x003b3;, TNF-&#x003b1; and GzmB in CD8<sup>+</sup>T<sub>MNP</sub> cells.</p><p id="P10">Polyfunctionality of CD8<sup>+</sup>T<sub>MNP</sub> cells, measured as simultaneous production of IFN-&#x003b3;, GzmB and TNF in response to stimulation, was similar to that of CD8<sup>+</sup>T<sub>EMRA</sub> cells (<xref rid="F4" ref-type="fig">Fig. 4b</xref>), as T<sub>MNP</sub> and T<sub>EMRA</sub> produced all three cytokines (50&#x02013;60%), TNF only (20&#x02013;25%), and TNF+IFN-&#x003b3; (15&#x02013;25%) at comparable frequencies to CD8<sup>+</sup>T<sub>EMRA</sub> cells, as opposed to T<sub>CM</sub> (~50% TNF<sup>+</sup> single producers) and T<sub>EM</sub> (&#x0003e;40% TNF<sup>+</sup>IFN-&#x003b3;<sup>+</sup> cells) (<xref rid="F4" ref-type="fig">Fig. 4b</xref>). Therefore, CD8<sup>+</sup>T<sub>MNP</sub> cells were highly polyfunctional. Moreover, about 40% of the IFN-&#x003b3;<sup>+</sup>GzmB<sup>+</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells also expressed perforin (<xref rid="F4" ref-type="fig">Fig. 4c</xref>) and all of the IFN-&#x003b3;<sup>+</sup>GzmB<sup>+</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells were CD107a<sup>+</sup> and thus were functionally lytic (<xref rid="F4" ref-type="fig">Fig. 4c</xref>). Therefore, CD8<sup>+</sup>T<sub>MNP</sub> cells were in a differentiated, polyfunctional state that contrasts with the quiescent, effector molecule-negative CD8<sup>+</sup>T<sub>N</sub> cells.</p><p id="P11">We next FCM-sorted CD49d<sup>hi</sup>CD45RA<sup>+</sup> CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells and compared their proliferation to CD49d<sup>lo</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD8<sup>+</sup>T<sub>N</sub>, T<sub>CM</sub> and T<sub>EM</sub> cells in response to the homeostatic cytokines IL-7 and IL-15. CD8<sup>+</sup>T<sub>MNP</sub> cells divided more in the presence of IL-7 or IL-7+ IL-15 than CD8<sup>+</sup>T<sub>N</sub> cells (<xref rid="F4" ref-type="fig">Fig. 4d</xref>; n=2, 35 and 67y, of n=8). In contrast to CD8<sup>+</sup>T<sub>N</sub> cells and similar to T<sub>CM</sub> and T<sub>EM</sub> subsets, CD8<sup>+</sup>T<sub>MNP</sub> cells also proliferated in response to IL-15 alone (<xref rid="F4" ref-type="fig">Fig. 4d</xref>), which is a cardinal characteristic of T<sub>M</sub> cells. When incubated with IL-15 for &#x0003e;3 days, CD49d<sup>hi</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells lost CCR7 and CD45RA expression faster than CD8<sup>+</sup>T<sub>N</sub> cells (<xref rid="F4" ref-type="fig">Fig. 4e</xref>). Regardless of that, CD122 (IL-15R&#x003b2;) expression was similar between CD8<sup>+</sup>T<sub>MNP</sub> (CD49<sup>hi</sup>-sorted T<sub>N</sub>) and CD8<sup>+</sup>T<sub>N</sub> (CD49<sup>lo</sup>-sorted T<sub>N</sub>; both CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>) (<xref rid="F3" ref-type="fig">Fig. 3b</xref>, <xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 2</xref>.). Finally, CD49<sup>hi</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells did not secrete IFN-&#x003b3; in response to overnight stimulation with IL-12+IL-18, suggesting that they cannot undergo Ag-nonspecific, bystander responses typical of other T<sub>M</sub> cells<sup><xref rid="R24" ref-type="bibr">24</xref></sup> (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 3a,b</xref>).</p><p id="P12">The above results suggested that T<sub>MNP</sub> cells could be partially activated via TCR. We therefore tested intracellular expression of T-bet (n=9, 24&#x02013;78y) and of phosphorylated Akt and ERK kinases (n=7, 35&#x02013;83y) in FCM-identified CD49d<sup>hi</sup>CD45RA<sup>+</sup> CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD8<sup>+</sup>T<sub>MNP</sub> and CD49d<sup>lo</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD8<sup>+</sup>T<sub>N</sub> cells, and compared it to T<sub>CM,</sub> T<sub>EM</sub> and T<sub>EMRA</sub> CD8<sup>+</sup> cells. Expression of T-bet, master transcription factor of T<sub>H</sub>1 cells<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup>, was increased significantly in CD8<sup>+</sup>T<sub>MNP</sub> cells compared to CD8<sup>+</sup>T<sub>N</sub> cells both in the steady-state (p&#x0003c;0.01) and following brief PMA+Iono activation (p&#x0003c;0.001; <xref rid="F4" ref-type="fig">Fig. 4f</xref>), and was not different (p=not significant) from T<sub>CM</sub> cells (<xref rid="F4" ref-type="fig">Fig. 4f</xref>). Akt and MAPK (Erk) kinases integrate multiple signaling cascades in T cells. We found no differences in pAKT levels between T<sub>MNP</sub> and T<sub>N</sub> cells (not shown). CD8<sup>+</sup>T<sub>MNP</sub> cells exhibited increased p-ERK at baseline compared to T<sub>N</sub> cells, and the difference increased following PMA+Iono stimulation (p&#x0003c;0.05; <xref rid="F4" ref-type="fig">Fig. 4g</xref>). Pre-incubation of CD8<sup>+</sup>T<sub>MNP</sub> cells with the Erk inhibitor U0126 decreased their IFN-&#x003b3; responses to PMA+Iono stimulation in a dose-dependent manner (<xref rid="F4" ref-type="fig">Fig. 4h</xref>), indicating that activated Erk pathway in CD8<sup>+</sup>T<sub>MNP</sub> cells mediated rapid cytokine production. No toxicity was observed at any dose of the inhibitor (not shown). Together, this demonstrates that CD8<sup>+</sup>T<sub>MNP</sub> cells are polyfunctional, exhibit cytolytic potential, can respond to IL-15 and constitutively activate the Erk pathway, which enables their capacity for rapid IFN-&#x003b3; responsiveness.</p></sec><sec id="S5"><title>T<sub>MNP</sub> cells have long telomeres and unique transcriptome</title><p id="P13">To explore whether CD8<sup>+</sup>T<sub>MNP</sub> cells were partially activated CD8<sup>+</sup>T<sub>N</sub> cells or differentiated CD8<sup>+</sup>T<sub>M</sub> cells that re-expressed naive markers, we evaluated their proliferative history and transcriptional profile. Telomeres are repeating hexameric sequences of nucleotides at chromosomal ends that provide genomic stability and that shorten with each replication. Telomeres are longer in T<sub>N</sub> cells and shorter in T<sub>M</sub> subsets<sup><xref rid="R27" ref-type="bibr">27</xref></sup> and can be used to estimate cell division history. We used multicolored fluorescent in-situ hybridization (flow-FISH) to compare the telomere length in CD8<sup>+</sup>T cell subsets (defined by CD45RA, CCR7, CD95, CD28 and CD49d as in <xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 4a</xref>). Telomere lengths in CD8<sup>+</sup>T<sub>MNP</sub> cells were comparable to those in CD8<sup>+</sup>T<sub>N</sub> cells (<xref rid="F5" ref-type="fig">Fig. 5a</xref>), suggesting that CD8<sup>+</sup>T<sub>MNP</sub> cells, unlike the other memory subsets, including CD8<sup>+</sup>T<sub>CM</sub>, T<sub>EM</sub> and T<sub>EMRA</sub>, did not undergo extensive division (<xref rid="F5" ref-type="fig">Fig. 5a</xref>). Therefore, telomere length in CD8<sup>+</sup>T<sub>MNP</sub> cells most closely resembled T<sub>N</sub> cells.</p><p id="P14">We next compared by RNASeq the transcriptome of CD8<sup>+</sup>T<sub>MNP</sub> cells, defined as IFN-&#x003b3;<sup>+</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>low</sup>CD28<sup>int</sup>, to other CD8 T cell subsets (IFN-&#x003b3;<sup>&#x02212;</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>low</sup>CD28<sup>int</sup> T<sub>N</sub> cells; other subsets as above, n=3&#x02013;5 subjects, 40&#x02013;76y). Differential gene expression among the T<sub>N</sub>, T<sub>CM</sub>, T<sub>EM</sub> and T<sub>EMRA</sub> CD8<sup>+</sup>T cell subsets (adjusted p&#x0003c;0.01, false discovery rate -FDR&#x0003c;0.05; <xref rid="F5" ref-type="fig">Fig. 5b</xref>), was distinguished by principal component (PC)1 variation. The variation captured by PC2 separated the T<sub>MNP</sub> subset (<xref rid="F5" ref-type="fig">Fig. 5b</xref>), and a combination of PC1 and PC2 variables indicated that T<sub>MNP</sub> cells were a unique T cell subset (<xref rid="F5" ref-type="fig">Fig. 5b</xref>) with similarities and differences to both CD8<sup>+</sup>T<sub>N</sub> and CD8<sup>+</sup>T<sub>CM</sub> on one hand and the more differentiated CD8<sup>+</sup> T<sub>EM</sub> and CD8<sup>+</sup>T<sub>EMRA</sub> on the other. A heat map of expression values for genes with the highest contributions to PC1 and PC2 (<xref rid="F5" ref-type="fig">Fig. 5c</xref>) indicated that T<sub>MNP</sub> clustered the closest to T<sub>N</sub>, followed by T<sub>CM</sub> and further away from T<sub>EM</sub> and T<sub>EMRA</sub> subsets (<xref rid="F5" ref-type="fig">Fig. 5c</xref>). The genes that placed the CD8<sup>+</sup>T<sub>MNP</sub> cells outside the canonical CD8<sup>+</sup>T<sub>N</sub> cluster included the effector genes (e.g. <italic>Ifng</italic>, <italic>Gzmb, Il1b</italic>, <italic>Cxcl3)</italic> and their expression in CD8<sup>+</sup>T<sub>MNP</sub> cells was similar or higher to that observed in CD8<sup>+</sup>T<sub>CM</sub> cells (<xref rid="F5" ref-type="fig">Fig. 5c</xref>). Conversely, genes like <italic>Nkg7, Fasl and Il22</italic> were not expressed in CD8<sup>+</sup>T<sub>MNP</sub> cells and that distinguished them from CD8<sup>+</sup>T<sub>EM</sub> and T<sub>EMRA</sub> (<xref rid="F5" ref-type="fig">Fig. 5c</xref>). Altogether, transcriptome data suggest that the CD8<sup>+</sup>T<sub>MNP</sub> cells are a unique T cell subset.</p></sec><sec id="S6"><title>CD8<sup>+</sup> T<sub>MNP</sub> cells are highly proliferative</title><p id="P15">We next explored proliferative potential of CD8<sup>+</sup>T<sub>MNP</sub> cells. We sorted IFN-&#x003b3;<sup>+</sup>CD45RA<sup>+</sup> CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells and their IFN&#x003b3; <sup>&#x02212;</sup>T<sub>N</sub> counterparts (<xref rid="SD2" ref-type="supplementary-material">Suppl. Fig. 5a</xref>; n=3; 63,65&#x00026;68y) or stimulated cells that were then separated by FCM into CD49d<sup>hi</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD8<sup>+</sup>T<sub>MNP</sub>, their CD49<sup>lo</sup>T<sub>N</sub> counterparts and T<sub>CM,</sub>, T<sub>EM</sub> and T<sub>EMRA</sub> cells (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 5b</xref>; n=5, 30&#x02013;80y). Stimulation was for 4h with anti-CD3+anti-CD28 antibodies for <xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 5a</xref>, to induce IFN-&#x003b3; and enable sorting. Cells were stimulated after sort for additional 3 days (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 5a</xref>) or with no sorting for 6 day (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 5b</xref>) with anti-CD3+anti-CD2+anti-CD28 antibody-coated beads in 10U IL-2. Division rates, measured using Cell Trace Violet dye dilution, revealed comparable proliferation between CD8<sup>+</sup>T<sub>MNP,</sub> CD8<sup>+</sup>T<sub>N</sub> and T<sub>CM</sub> cells (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 5a</xref>). We conclude that, consistent with their long telomeres, T<sub>MNP</sub> cells possess robust proliferative potential.</p></sec><sec id="S7"><title>T<sub>MNP</sub> cells respond to persistent viruses</title><p id="P16">We next examined TCR diversity of CD8<sup>+</sup>T<sub>MNP</sub> by FCM using 24 Ab specific for the TCR &#x003b2;-chain variable region (TCR V&#x003b2;), covering 70% of the total TCRV&#x003b2; repertoire. Compared to CD49d<sup>lo</sup> CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>28<sup>int</sup>CD8<sup>+</sup>T<sub>N</sub>, CD49d<sup>hi</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>28<sup>int</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells showed a restricted distribution of TCR V&#x003b2; segments, similar to the highly differentiated CD8<sup>+</sup>T<sub>EMRA</sub> cells (<xref rid="F6" ref-type="fig">Fig. 6a</xref>; n=3/11 shown; 24&#x02013;80y). This suggested that CD8<sup>+</sup> T<sub>MNP</sub> cells could arise in response to antigens that drive the generation of the CD8<sup>+</sup>T<sub>EM</sub> and CD8<sup>+</sup>T<sub>EMRA</sub>, rather than due to broad, cytokine-driven memory conversion. Longitudinal comparison of CD8<sup>+</sup>T<sub>MNP</sub> TCR V&#x003b2; profile in a representative 50y old subject (of n=2, 50 and 73y) over 24 months showed a stable dominant TCR V&#x003b2;14 clonal expansion (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 6</xref>), suggesting that CD8<sup>+</sup>T<sub>MNP</sub> cells are stably maintained by TCR-driven signals.</p><p id="P17">CD8<sup>+</sup>T<sub>EMRA</sub> cells are often specific for persistent viruses<sup><xref rid="R28" ref-type="bibr">28</xref></sup>. To assess whether the CD8<sup>+</sup>T<sub>MNP</sub> cells shared that specificity, we stimulated PBMC (n=8 subjects, 24&#x02013;80y) for 3h with overlapping 15-mer peptides covering the length of viral proteins. In a representative 66y old donor T<sub>MNP</sub> cells made up 8.5% of the total response against the Epstein-Barr virus (EBV) BZLF1 protein, and 1.4% of the response against the cytomegalovirus (CMV) pp65, but no response against the influenza A virus (IAV) matrix protein (<xref rid="F6" ref-type="fig">Fig. 6b</xref>). A similar fraction of CD8<sup>+</sup>T<sub>MNP</sub> cells responded to HIV-1 Gag peptide pool in two out of three HIV-infected subjects undergoing HAART therapy, (<xref rid="F6" ref-type="fig">Fig. 6c</xref>). Controls were treated with brefeldin A (negative) or PMA+Iono (positive).</p><p id="P18">We extended these observations by FCM staining of unstimulated PBMC and identification of Ag-specific cells with peptide-major histocompatibility complex class I (pMHCI) multimers. The majority (&#x0003e;90%) of CD8<sup>+</sup>T cells specific for HLA-A*0201 bearing immunodominant CMV pp65 NLVPMATM and EBV BMLF1 GLCTLVAML peptides in CMV<sup>+</sup> (n=26) and EBV<sup>+</sup> subjects (n=7), respectively, exhibited the T<sub>EM, CM or TEMRA</sub> phenotype (<xref rid="F7" ref-type="fig">Fig. 7a,b</xref>). However, phenotypically na&#x000ef;ve CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD8<sup>+</sup> T cells also bound CMV and EBV pMHCI multimers (<xref rid="F7" ref-type="fig">Fig. 7a,b</xref>,) and a substantial fraction (25% and 12.4% for CMV and EBV, respectively) of them also produced IFN-&#x003b3; following a 3h stimulation with PMA+Iono (<xref rid="F7" ref-type="fig">Fig. 7a,b</xref>). PMA+Iono stimulation did not induce TCR down-regulation and did not affect pMHC binding (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 4b</xref>). In contrast, we found no IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup> cells in the identically gated CD8<sup>+</sup>T<sub>N</sub> cells that bound pMHCI multimers in CMV- or EBV-negative subjects (<xref rid="F7" ref-type="fig">Fig. 7a,b</xref>). T<sub>MNP</sub> cells were present at similar frequencies (75% and 67% of CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD8<sup>+</sup>cells that bound pMHC multimers) in two subjects that had tenfold different overall T cell responses to EBV (<xref rid="F7" ref-type="fig">Fig. 7b</xref>). These results suggest that the CD8<sup>+</sup>T<sub>MNP</sub> cells arise as a part of a response to persistent viral antigens.</p><p id="P19">To test whether the CD8<sup>+</sup> T<sub>MNP</sub> cells also respond to acute viral pathogens, we FCM-stained vaccinia virus (VACV) vaccinated, CMV<sup>+</sup> donor PBMC with the CMV pMHC tetramer pp65:HLA-A*0201 and the VACV tetramer CLT:HLA-A*0201. CD8<sup>+</sup>T<sub>MNP</sub> cells, as scored by production of IFN-&#x003b3; following PMA+Iono stimulation, were found amongst CMV-pMHC<sup>+</sup> but not VACV-pMHC<sup>+</sup> population (<xref rid="F7" ref-type="fig">Fig. 7c</xref>). We also failed to detect IFN-&#x003b3;<sup>+</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells specific for the melanoma self-antigen Melan-A/Mart-1<sup><xref rid="R29" ref-type="bibr">29</xref></sup> in a healthy, melanoma-negative subjects (<xref rid="F7" ref-type="fig">Fig. 7d</xref>), where all Melan-A/Mart-1<sup>+</sup> cells were CD49d<sup>&#x02212;</sup>IFN-&#x003b3;<sup>&#x02212;</sup> (<xref rid="F7" ref-type="fig">Fig. 7d</xref>). Therefore, CD8<sup>+</sup>T<sub>MNP</sub> cells are driven by persistent viral infections and do not respond to vaccine or self-antigens.</p></sec><sec id="S8"><title>CD8<sup>+</sup> T<sub>MNP</sub> cells are linked to past severe infections</title><p id="P20">Because the size and diversity of na&#x000ef;ve T cells pool determines the ability to generate protection against new infections<sup><xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup>, we investigated whether the frequency and number of CD8<sup>+</sup>T<sub>MNP</sub> cells correlated to the immune fitness against acute infections. We compared the frequency of CD8<sup>+</sup>T<sub>MNP</sub> cells amongst T<sub>N</sub> cells longitudinally from days 2&#x02013;90 post-diagnosis, in a cohort of WNV infected subjects who either lacked or presented clinical symptoms, such as fever, meningitis and/or encephalitis. Of the CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>28<sup>int</sup> naive phenotype T cells, three asymptomatic subjects (of n=11 shown, 39&#x02013;92y) had 0.3&#x02013;1.6% IFN-&#x003b3;<sup>+</sup>CD49d<sup>hi</sup> and 0.3&#x02013;5.9% GzB<sup>+</sup>CD49d<sup>hi</sup>T<sub>MNP</sub> cells, whereas three (n=16 analyzed, 43&#x02013;84 y) symptomatic subjects contained 14.2&#x02013;20.8% and 12.6&#x02013;19.8% of these cells, respectively(<xref rid="F8" ref-type="fig">Fig. 8a, b</xref>). Furthermore, the average absolute numbers of CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>28<sup>int</sup>IFN-&#x003b3;<sup>+</sup>CD49d<sup>hi</sup> CD8<sup>+</sup>T<sub>MNP</sub> cells were &#x0003c;2,000/10<sup>6</sup> CD8<sup>+</sup> and &#x0003e;4,000/10<sup>6</sup> CD8<sup>+</sup> cells in asymptomatic and symptomatic patients, respectively (<xref rid="F8" ref-type="fig">Fig 8c</xref>), with no differences in the numbers of CD8<sup>+</sup>T<sub>N</sub>, T<sub>CM</sub>, T<sub>EM</sub> or T<sub>EMRA</sub> cells (<xref rid="SD2" ref-type="supplementary-material">Supplementary Fig. 8</xref>). WNV infection resulted in an expansion of CD8<sup>+</sup>T<sub>MNP</sub> cells in symptomatic but not asymptomatic subjects, evidenced by an increase in CD8<sup>+</sup>T<sub>MNP</sub>/10<sup>6</sup> CD8<sup>+</sup>T cells between d2&#x02013;7 and d60&#x02013;90 post-infection (<xref rid="F8" ref-type="fig">Fig. 8d</xref>). This shows that frequency and numbers of T<sub>MNP</sub> cells positively correlate with the severity of acute viral infection.</p></sec></sec><sec sec-type="discussion" id="S9"><title>DISCUSSION</title><p id="P21">Here, we characterized a novel subset of T cells that appeared functionally differentiated and activated, but which underwent only minimal phenotypic changes compared to CD8<sup>+</sup>T<sub>N</sub> cells and continued to express molecules associated with a naive T cell state. The frequency of these CD8<sup>+</sup>T<sub>MNP</sub> cells increased with aging. They were polyfunctional and exhibited increased baseline phosphorylation of Erk, suggesting that they were receiving TCR-mediated signals. Their skewed TCRV&#x003b2; utilization and TCR specificity for persistent, but not acute, viruses or vaccines, confirmed that CD8<sup>+</sup>T<sub>MNP</sub> cells represent a T cell activation stage that allows persistence of antigen-primed, effector-ready T cells in a nearly-naive state.</p><p id="P22">We speculate that T<sub>MNP</sub> cells are functionally imprinted at an early stage of differentiation and propose that they represent a third line of defense against persistent viral infections, behind T<sub>EM</sub> and T<sub>CM</sub> cells. Their <italic>in vitro</italic> differentiation with IL-7+IL-15 suggested that CD8<sup>+</sup>T<sub>MNP</sub> cells maintain their plasticity and can give rise to cells that resemble CD8<sup>+</sup>T<sub>CM</sub>, T<sub>EM</sub> and T<sub>EMRA</sub> cells. This is consistent with the observation that CD8<sup>+</sup>T<sub>MNP</sub> cells did not respond to the inflammatory cytokines IL-12 and IL-18 by IFN-&#x003b3; production, as would be expected of highly differentiated T<sub>EM</sub> and T<sub>EMRA</sub> cells. Their telomere lengths were comparable to that of CD8<sup>+</sup>T<sub>N</sub> cells, suggesting they have not undergone extensive proliferation associated with full effector and memory differentiation. Consistent with all of the above, unsupervised and unbiased analysis of the CD8<sup>+</sup>T<sub>MNP</sub> cells transcriptome classified them as a unique subset, clustering between CD8<sup>+</sup>T<sub>N</sub> and T<sub>CM</sub> subsets, further apart from terminally differentiated CD8<sup>+</sup>T<sub>EM</sub> and T<sub>EMRA</sub>.</p><p id="P23">T<sub>MNP</sub> cells were the only CD8<sup>+</sup> subset whose numbers and frequency expanded in the course of, and correlated with, symptomatic, severe WNV disease. This could be because acute viral infection led to persistent virus reactivation, or for other reasons that remain to be investigated. Despite this, we do not believe these cells are pathogenic or that they contribute to immune dysfunction in a direct, antigen-specific manner. This is because CD8<sup>+</sup>T<sub>MNP</sub> cells expressed CXCR3 and CD49d, allowing them to traffic rapidly to inflamed tissues and engage in virus control using their polyfunctional secretion of T<sub>H1</sub> cytokines and cytotoxic granules. However, because their numbers also correlated with deterioration of the na&#x000ef;ve T cell pool, they could serve as a biomarker for immune vulnerability. Specifically, their presence in the CD8<sup>+</sup>T<sub>N</sub> pool could be marker of low T<sub>N</sub> fitness due the fact that T<sub>MNP</sub> cells mask an even more pronounced decrease in CD8<sup>+</sup>T<sub>N</sub> pool size and diversity, which often manifests as an impaired ability to generate optimal immunity against new infections or immunization<sup><xref rid="R32" ref-type="bibr">32</xref></sup>.</p><p id="P24">Increasing our knowledge about qualitative and quantitative changes in the aging human immune system could help improve immune interventions for older adults, by stratifying at-risk populations and customizing intervention strategies. Indeed, our understanding of the complexity of T cell subset phenotype and function has greatly increased since the original classification into na&#x000ef;ve, effector and memory subsets<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup>. Technical advances have allowed the identification of new T cell subpopulations<sup><xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref></sup>. While numerous (&#x0003e;200) transient populations were observed in a study combining phenotypic, functional and antigen specific tetramer-based markers<sup><xref rid="R18" ref-type="bibr">18</xref></sup>, some of them form functionally defined, stable subsets, such as resident memory T cells<sup><xref rid="R36" ref-type="bibr">36</xref></sup>, T stem cell memory<sup><xref rid="R37" ref-type="bibr">37</xref></sup>, recent thymic immigrants<sup><xref rid="R38" ref-type="bibr">38</xref></sup>, early memory CD4<sup>+</sup>T cells<sup><xref rid="R39" ref-type="bibr">39</xref></sup> and self-renewing memory CD8<sup>+</sup>T cells resistant to chemotherapy<sup><xref rid="R40" ref-type="bibr">40</xref></sup>. CD8<sup>+</sup>T<sub>MNP</sub> cells add to the complexity of the primary T cell response during aging and to our understanding of the generation of an immune response to persistent viruses. Additional work is needed to address whether the T<sub>MNP</sub> developmental fate intersects with any of the above subsets. In that regard, it will be of interest to directly compare CD8<sup>+</sup>T<sub>MNP</sub> cells with the CD8<sup>+</sup>T<sub>SCM</sub> cells<sup><xref rid="R37" ref-type="bibr">37</xref></sup>, even if indirect comparisons<sup>37, this study</sup> suggest important differences in expression of CD95, CD11a, CD122, CD31, proliferation history and specificity, where T<sub>SCM</sub>, unlike T<sub>MNP</sub>, cells respond to acute infections<sup><xref rid="R37" ref-type="bibr">37</xref></sup>.</p><p id="P25">Overall, CD8<sup>+</sup>T<sub>MNP</sub> cells should be considered when developing immune interventions that rely on the na&#x000ef;ve T cell pool<sup><xref rid="R41" ref-type="bibr">41</xref></sup>. These cells could be useful if immunotherapy is aimed at targeting persistent infections, or should be accounted for if truly na&#x000ef;ve T cells are needed to respond to antigens.</p></sec><sec id="S10"><title>PUBLIC DATA AVAILABILITY</title><p id="P26">RNASeq data set described in <xref rid="F5" ref-type="fig">Fig. 5</xref> is available to public via the National Library of Medicine Gene Expression Omnibus at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/under">http://www.ncbi.nlm.nih.gov/geo/under</ext-link> the accession number GSE80306. Raw data for all other results shown in the manuscript will be available via the NIAID ImmPort database at <ext-link ext-link-type="uri" xlink:href="http://immport.org/immport-open/public/study/study/displayStudyDetail/SDY736">http://immport.org/immport-open/public/study/study/displayStudyDetail/SDY736</ext-link>&#x0201d;.</p></sec><sec id="S11" specific-use="web-only"><title>ONLINE METHODS</title><sec id="S12" sec-type="methods|subjects"><title>Study Subjects and Blood Samples</title><p id="P27">This study was approved by the Institutional Review Boards at the University of Arizona (Tucson, AZ; # 080000673), the Oregon Health and Science University (Portland, OR; # IRB00003007), the University of Texas HSC at Houston (Houston, TX), the Vaccine and Gene Therapy Institute-Florida (Port St. Lucie, FL) and the Blood Systems Research Institute (San Francisco, CA). Human samples were obtained from healthy donors, age 21&#x02013;101 y of age, as indicated in each experiment, recruited at the OHSU, the University of Arizona or the Martin Health system (Florida) over the period of 6 years. Exclusion criteria included known immunosuppressive pathology, stroke, cancer, or use of steroids within the last 5 years. WNV infected donors were enrolled by Blood Systems Research Institute (BSRI) between 2009 and 2011 or by the University of Texas at Houston, between 2006&#x02013;2009. Samples, demographics and symptoms data were collected and analyzed as previously described <sup><xref rid="R42" ref-type="bibr">42</xref></sup> after the subjects provided an informed consent approved by the UCSF Committee on Human Research (protocol # 10-01255) or the Committee for the Protection of Human Subjects at the University of Texas Health Science Center at Houston (HSC-SPH-03-039), respectively. Exclusion criteria included known immunosuppressive status, stroke, cancer, or the use of steroids within the last 5 years. Blood was drawn into heparinized Vacutainer CPT tubes (BD Bioscience, Franklin Lakes, NJ) and processed fresh at respective sites per manufacturer&#x02019;s recommendations to isolate peripheral blood mononuclear cells (PBMC) and plasma; K<sub>2</sub>-EDTA tubes were used to determine complete blood counts. Peripheral blood mononuclear cells were also isolated from leukapheresis using Ficoll-Paque (GE Healthcare, NJ, USA) density gradient media. PBMCs were frozen in 90% fetal bovine serum (FBS) and 10% DMSO. Initial observational experiment (<xref rid="F1" ref-type="fig">Fig. 1a,b</xref>) was performed on subjects selected randomly to meet age criteria and ensured adequate power, as described in our previous work <sup><xref rid="R2" ref-type="bibr">2</xref></sup>. Unless stated otherwise, subsequent experiments were performed using subgroups of subjects defined by age and &#x0003e;5% na&#x000ef;ve T cell responsiveness measured in <xref rid="F1" ref-type="fig">Fig. 1a,b</xref>) and selected by A.M.W. randomly based on these criteria, without input of V.P., who did the experiments. In these studies, we initially did not observe, and subsequently did not follow, sex differences in T<sub>VN</sub> cell abundance. Experiments, data collection and Flow Jo analysis were performed blindly up to the point of final analysis as samples associated specific subject ID did not contain information about their age.</p></sec><sec id="S13"><title>Antibodies, Flow Cytometry and Cell Sorting</title><p id="P28">All antibodies, dilutions and validation are provided in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 1</xref>. TCR-V&#x003b2; specificity was evaluated by IOTest&#x000ae; Beta Mark Kit (Beckman Coulter). HLA-A2 CMV-NLV, HLA-A2 VV-CLT, and HLA-A2 Melan-A-ELA tetramers were obtained from the NIH tetramer core facility at Emory University, HLA-A2 INF-GIL tetramers were generously provided by Dr. K. Kedzierska&#x02019;s laboratory at the University of Melbourne, Melbourne, Australia and HLA-A2 EBV-GLC dextramers were obtained from IMMUDEX (Copenhagen, Denmark).</p><p id="P29">Frozen PBMCs were thawed in RPMI medium supplemented with 10% FBS, penicillin and streptomycin in the presence of DNAse (Sigma, Saint Louis, MO), rested overnight in X-Vivo medium (Lonza/Basel, Switzerland) supplemented with 5% human male AB serum and used for surface and intracellular staining at 1&#x02013;3 &#x000d7; 10<sup>6</sup> per sample. Cells were first stained with LIVE/DEAD&#x000ae; Fixable Dead Cell Stain (Life technologies, Eugene, OR), and next incubated with various combinations of antibodies against T cell markers (both for 30 min at 4&#x000b0;C). Tetramers were added 30 min prior to antibodies against other surface markers. For intracellular staining, cells were permeabilized with FACS Permeabilization solution (BD Biosciences or eBiosciences) and incubated with antibodies against various intracellular molecules for 30 min at 4&#x000b0;C. Flow cytometry acquisition was performed on a custom-designed BD Biosciences Fortessa and analyzed using FlowJo software (Tree Star, Ashland, OR). T cell subsets were sorted using a modified FACSAria (BD Biosciences).</p></sec><sec id="S14"><title>Stimulation Assays</title><p id="P30">PBMCs were stimulated with either PMA/Iono (Cell stimulation cocktail, eBioscience), plate-bound CD3/CD49d/soluble CD28 (at 10 &#x003bc;g/mL, 5 &#x003bc;g/mL, and 5 &#x003bc;g/mL respectively) or with peptides or their mixtures [Influenza Matrix peptide<sub>57&#x02013;66</sub> (AnaSpec, San Jose, CA), EBV BZLF-1 peptide pool, CMV pp65 peptide pool (both Miltenyi Biotec, San Diego, CA) or HIV-1 PTE Gag peptide pool<sup><xref rid="R43" ref-type="bibr">43</xref></sup> (obtained from the NIH AIDS reagent program)] for 3 hrs in the presence of brefeldin A (eBioscience). All peptides were used according to manufacturer&#x02019;s instructions at approximately 1 &#x003bc;g/mL of each peptide; peptide mixtures were constructed as sets of 15-mers overlapped by 9 amino acids. Phenotype and cytokine production were evaluated by flow cytometry as described above. In the phospho ERK blocking experiment, MAPK inhibitor U0126 (Tocris Bioscience, Bristol, UK) was added to PBMCs for 3 h prior stimulation with PMA/Iono.</p></sec><sec id="S15"><title>Phos-Flow</title><p id="P31">PBMCs were stimulated with PMA/Ionomycin for 5, 10 or 15 min and simultaneously stained with antibodies against surface markers and phospho-Erk (Thr202/Tyr204) using BD Biosciences Phos-flow fixation and permeabilization solutions according to manufacturer&#x02019;s protocol.</p></sec><sec id="S16"><title>Cytokine Proliferation Assays</title><p id="P32">PBMCs were thawed, labeled with Cell trace violet (CTV) proliferation dye (Molecular Probes, Eugene, OR) according to manufacturer&#x02019;s instructions (2 &#x003bc;M at 5 &#x000d7; 10<sup>6</sup> cells/mL for 30 min at 37&#x000b0;C) and rested over night. The next day, various T cell subsets were isolated by cell sorting and incubated in the presence of cytokines [IL-7 (50 ng/mL), IL-15 (50 ng/mL) (both R&#x00026;D Systems, Minneapolis, MN), IL-12 (5 ng/mL; Peprotech, Rocky Hill, NJ) or IL-18 (5 ng/mL; Life Technologies, Eugene, OR)]. On day 3 or 7, phenotype, proliferation (dilution of CTV proliferation dye) and/or cytokine production were evaluated by flow cytometry.</p></sec><sec id="S17"><title>Sorting of IFN&#x003b3;<sup>+</sup> Secretion Assay</title><p id="P33">PBMCs were thawed, labeled with CTV and rested overnight. The next day, phenotypically na&#x000ef;ve IFN&#x003b3; producing cells (<bold>T<sub>VN</sub></bold>) and nonproducing (<bold>T<sub>N</sub></bold>) CD8<sup>+</sup> T cells were isolated using an IFN&#x003b3; secretion assay cell enrichment and detection kit (Miltenyi Biotec) and cell sorting. Briefly, cells were transferred onto CD3 coated plates (10 &#x003bc;g/mL; in the presence of soluble CD28 at 5 &#x003bc;g/mL), stimulated for 3 h at 37&#x000b0;C, labeled with IFN&#x003b3; specific capture antibody reagent and incubated for 45 min at 37&#x000b0;C (while slowly rotating). Next, the cells were concurrently incubated with IFN&#x003b3; detection antibody and antibodies against the remaining phenotypic T cell markers, which allowed for identification of naive T cell subset. IFN&#x003b3; producing and nonproducing na&#x000ef;ve CD8<sup>+</sup> T cell subsets were isolated by cell sorting and incubated in the presence of CD3/CD2/CD28 coated beads (T cell activation/expansion kit, Miltenyi Biotec) at ratio 1:1 in the presence of IL-2 (100 U/mL) for 3 days, when proliferation and phenotype were evaluated by flow cytometry.</p></sec><sec id="S18"><title>SPADE analysis</title><p id="P34">Spanning-tree progression analysis of density-normalized events (SPADE) clustering algorithm <sup><xref rid="R44" ref-type="bibr">44</xref></sup> on the Cytobank.org platform was used to analyze doublet-exclused, alive CD8b<sup>+</sup> lymphocytes from nine subjects. This produced an interconnected cluster of nodes, or clusters of connected nodes, that correspond with phenotypically defined CD8 T cell populations.</p></sec><sec id="S19"><title>Multi-color flow-FISH</title><p id="P35">Experiment was performed according to modified manufacturer&#x02019;s protocol as described by Ridell et al. <sup><xref rid="R45" ref-type="bibr">45</xref></sup>. Briefly, PBMCs were first stained with LIVE/DEAD&#x000ae; Fixable Dead Cell Stain and then incubated with biotinylated CD28 or directly conjugated antibodies (CD45RA (BV711), CCR7 (FITC), CD3 (BV570), CD95 (BV421), CD49d (BV510), CD8&#x003b1; (BV650)), followed by 15 min incubation with streptavidin-conjugated Cy3. Cells were fixed and permeabilized using FACS Fixation and permeabilization kit (BD Biosciences). Samples were than washed in PBS, fixed in 1mM BS3 (30 min on ice, ThermoFisher Scientific) and quenched with 50mM Tris-HCl in PBS (pH 7.2, 20 min, room temperature). The cells were washed twice; first in PBS, and then in hybridization buffer (70% deionized formamide, 28.5mM Tris-HCl pH7.2, 1.4% BSA and 0.2M NaCl). The samples were subsequently resuspended in hybridization buffer and incubated with of the PNA TelC &#x02013;Cy5 probe (200 nM, PNA Bio Inc, Thousand Oaks, CA) and heated for 10 min at 82C, rapidly cooled on ice and left to hybridize for 1 hr at room temperature in the dark. Lastly, the samples were washed in post-hybridization buffer (70% deionized formamide, 14.25mM Tris-HCl pH7.2, 0.14% BSA, 0.2M NaCl and 0.14% Tween-20) and in PBS 2% BSA before acquisition on BD Biosciences Fortessa and analyzed using FlowJo software. Unless stated otherwise, chemicals were purchased from Sigma-Aldrich (St. Louis, MO).</p></sec><sec id="S20"><title>RNA sequencing</title><p id="P36">T cell samples from sorted populations were obtained for genome-wide expression profiling by RNA-Seq. There was a broad range of cell numbers available from the different populations (some samples had down to a few thousand cells), and so a strategy for low-input RNA-Seq across all of the samples was employed. Trizol extraction was followed by isopropanol precipitation to obtain total RNA. Each total RNA sample was re-suspended in 20 uL of Elution Solution (nuclease-free water supplemented with 0.5 U/uL RNase inhibitor (SUPERase IN, Life Technologies)). To isolate mRNA, LNA-oligo(dT) was used rather than DNA-oligo(dT). LNA is an analog of RNA with a modified sugar backbone that imparts a much higher melting point <sup><xref rid="R46" ref-type="bibr">46</xref></sup> and therefore facilitates high sensitivity mRNA capture. Biotinylated LNA-Oligo(dT) (Exiqon) was attached to streptavidin-coated superparamagnetic beads (C1 Dynabeads, Life Technologies) in Hybridization Buffer (20 mM Tris pH 8, 1 M NaCl, 0.1% tween-20). After washing the beads three times in Wash Buffer (20 mM Tris pH 8, 50 mM NaCl, 0.1% tween-20) and re-suspending in Hybridization Buffer, 20 uL of beads were added to each total RNA sample and the mixture was incubated for 45 minutes at room temperature on a rotisserie. After washing the beads three times with Wash Buffer and re-suspending in 15 uL of Elution Solution, the bead mixture was heated to 75C for two minutes followed by immediate removal of the supernatant containing purified mRNA.</p><p id="P37">Strand-specific RNA-Seq libraries were constructed using the template-switching strategy implemented in the SMARTer Stranded RNA-Seq kit (Clontech). mRNA fragmentation reactions were run for four minutes and cDNA was purified twice with size selection beads (Ampure XP, Beckman) prior to PCR enrichment. Libraries were sequenced on an Illumina NextSeq 500 sequencer with 75-base single-end reads. The reads were mapped to the Ensembl GRCh37 human genome and transcriptome annotation (obtained from Illumina iGenomes) using Tophat2 <sup><xref rid="R47" ref-type="bibr">47</xref></sup> and the uniquely mapped reads associated with each gene using HTseq were counted <sup><xref rid="R46" ref-type="bibr">46</xref></sup>. Differential expression analysis between different T cell populations was constructed using DESeq2 <sup><xref rid="R48" ref-type="bibr">48</xref></sup>. Normalization was performed with samples within cell types as biological replicates. The counts were transformed using the regularized log transformation provided in the DESeq2 package as described in <sup><xref rid="R48" ref-type="bibr">48</xref></sup>. Principal component analysis was done based on all genes annotated from the Consensus Coding Sequence (CCDS) Project<sup><xref rid="R49" ref-type="bibr">49</xref></sup>. The figures were produced using ggplot2 <sup><xref rid="R50" ref-type="bibr">50</xref></sup> and gplots <sup><xref rid="R51" ref-type="bibr">51</xref></sup> packages from R programming language.</p></sec></sec><sec sec-type="supplementary-material" id="S21"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS784701-supplement-1.doc" orientation="portrait" xlink:type="simple" id="d37e2869" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>2</label><media xlink:href="NIHMS784701-supplement-2.pdf" orientation="portrait" xlink:type="simple" id="d37e2873" position="anchor"/></supplementary-material></sec></body><back><ack id="S22"><p>The authors would like to acknowledge Ms. P. Campbell of the Arizona Cancer Center, Arizona Research Laboratory Flow Cytometry Core Facility for expert sorting and the Arizona Cancer Center Support Grant (NCI - CA 023074) for facility support; NIH Tetramer Facility for outstanding reagent preparation; Dr K. Kedzierska (University of Melbourne) for generous donation of key tetramer reagents; and the members of the Nikolich, Kuhns, Frelinger, Wu and Schenten laboratories at the University of Arizona for insight and helpful discussions. This work was supported by the NIAID contract N01-AI00017, the NHLBI grant RC2HL101 and the NIA grants R01 AG-048021 and P30 AG008017 from the National Institutes of Health and by the Bowman Endowed Professorship in Medical Research to J.N-&#x0017d;.</p></ack><fn-group><fn id="FN2" fn-type="con"><p><bold>AUTHOR CONTRIBUTION STATEMENT:</bold> VP and JN&#x0017d; designed and analyzed experiments. VP performed stimulation analysis, cell sorting and RNA isolation. JSD performed flow cytometry and SPADE analysis. CM KOM and AMW performed subject consenting, blood draws, sample organization and human subject database searching and sample management for Arizona, Oregon and Texas subjects. MCL and MPB provided WNV-exposed samples from the San Francisco Blood Bank. MSD facilitated sample transfer. KOM provided WNV-exposed subject samples from the Houston area. KK provided HIV+ subject samples. ESB and PAS performed the RNASeq experiments, and together with VP, JSD, SS and DB, performed RNASeq data analysis. EKH provided subject samples and critical design input. VP and JN&#x0017d; wrote the manuscript. JSD, MCL, MPB, MSD, KK, PAS, DB and AWM edited the manuscript. JN&#x0017d; conceived the study.</p></fn><fn id="FN3" fn-type="conflict"><p><bold>COMPETING FINANCIAL INTERESTS</bold></p><p>Authors declare no competing financial interests.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>MK</given-names></name><name><surname>Chu</surname><given-names>HH</given-names></name><name><surname>McLachlan</surname><given-names>JB</given-names></name><name><surname>Moon</surname><given-names>JJ</given-names></name></person-group><article-title>On the composition of the preimmune repertoire of T cells specific for Peptide-major histocompatibility complex ligands</article-title><source>Annu Rev Immunol</source><year>2010</year><volume>28</volume><fpage>275</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">20307209</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wertheimer</surname><given-names>AM</given-names></name><name><surname>Bennett</surname><given-names>MS</given-names></name><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Uhrlaub</surname><given-names>JL</given-names></name><name><surname>Martinez</surname><given-names>C</given-names></name><name><surname>Pulko</surname><given-names>V</given-names></name><etal/></person-group><article-title>Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans</article-title><source>J Immunol</source><year>2014</year><volume>192</volume><issue>5</issue><fpage>2143</fpage><lpage>2155</lpage><pub-id pub-id-type="pmid">24501199</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolich-Zugich</surname><given-names>J</given-names></name></person-group><article-title>Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections</article-title><source>Nat Rev Immunol</source><year>2008</year><volume>8</volume><issue>7</issue><fpage>512</fpage><lpage>522</lpage><pub-id pub-id-type="pmid">18469829</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Glanville</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Diversity and clonal selection in the human T-cell repertoire</article-title><source>Proc Natl Acad Sci U S A</source><year>2014</year><volume>111</volume><issue>36</issue><fpage>13139</fpage><lpage>13144</lpage><pub-id pub-id-type="pmid">25157137</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linton</surname><given-names>PJ</given-names></name><name><surname>Dorshkind</surname><given-names>K</given-names></name></person-group><article-title>Age-related changes in lymphocyte development and function</article-title><source>Nat Immunol</source><year>2004</year><volume>5</volume><issue>2</issue><fpage>133</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">14749784</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cambier</surname><given-names>J</given-names></name></person-group><article-title>Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling</article-title><source>Immunol Rev</source><year>2005</year><volume>205</volume><fpage>5</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15882340</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goronzy</surname><given-names>JJ</given-names></name><name><surname>Weyand</surname><given-names>CM</given-names></name></person-group><article-title>T cell development and receptor diversity during aging</article-title><source>Curr Opin Immunol</source><year>2005</year><volume>17</volume><issue>5</issue><fpage>468</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">16098723</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>RA</given-names></name></person-group><article-title>Effect of aging on T lymphocyte activation</article-title><source>Vaccine</source><year>2000</year><volume>18</volume><issue>16</issue><fpage>1654</fpage><lpage>1660</lpage><pub-id pub-id-type="pmid">10689144</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>WW</given-names></name><name><surname>Shay</surname><given-names>DK</given-names></name><name><surname>Weintraub</surname><given-names>E</given-names></name><name><surname>Brammer</surname><given-names>L</given-names></name><name><surname>Cox</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Mortality associated with influenza and respiratory syncytial virus in the United States</article-title><source>JAMA</source><year>2003</year><volume>289</volume><issue>2</issue><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">12517228</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>LR</given-names></name><name><surname>Roehrig</surname><given-names>JT</given-names></name><name><surname>Hughes</surname><given-names>JM</given-names></name></person-group><article-title>West Nile virus encephalitis</article-title><source>N Engl J Med</source><year>2002</year><volume>347</volume><issue>16</issue><fpage>1225</fpage><lpage>1226</lpage><pub-id pub-id-type="pmid">12270973</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinn</surname><given-names>IK</given-names></name><name><surname>Blackburn</surname><given-names>CC</given-names></name><name><surname>Manley</surname><given-names>NR</given-names></name><name><surname>Sempowski</surname><given-names>GD</given-names></name></person-group><article-title>Changes in primary lymphoid organs with aging</article-title><source>Semin Immunol</source><year>2012</year><volume>24</volume><issue>5</issue><fpage>309</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">22559987</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolich-Zugich</surname><given-names>J</given-names></name></person-group><article-title>Aging of the T cell compartment in mice and humans: from no naive expectations to foggy memories</article-title><source>J Immunol</source><year>2014</year><volume>193</volume><issue>6</issue><fpage>2622</fpage><lpage>2629</lpage><pub-id pub-id-type="pmid">25193936</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Albright</surname><given-names>JF</given-names></name><name><surname>Albright</surname><given-names>JW</given-names></name></person-group><source>Aging, Immunity and Infection</source><publisher-name>Humana Press</publisher-name><publisher-loc>Totowa</publisher-loc><year>2003</year></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maecker</surname><given-names>HT</given-names></name><name><surname>McCoy</surname><given-names>JP</given-names></name><name><surname>Nussenblatt</surname><given-names>R</given-names></name></person-group><article-title>Standardizing immunophenotyping for the Human Immunology Project</article-title><source>Nat Rev Immunol</source><year>2012</year><volume>12</volume><issue>3</issue><fpage>191</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">22343568</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sallusto</surname><given-names>F</given-names></name><name><surname>Geginat</surname><given-names>J</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group><article-title>Central memory and effector memory T cell subsets: function, generation, and maintenance</article-title><source>Annu Rev Immunol</source><year>2004</year><volume>22</volume><fpage>745</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">15032595</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><article-title>Effector and memory T-cell differentiation: implications for vaccine development</article-title><source>Nat Rev Immunol</source><year>2002</year><volume>2</volume><issue>4</issue><fpage>251</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">12001996</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Ernst</surname><given-names>B</given-names></name><name><surname>Kieper</surname><given-names>W</given-names></name><name><surname>LeRoy</surname><given-names>E</given-names></name><name><surname>Sprent</surname><given-names>J</given-names></name><name><surname>Surh</surname><given-names>C</given-names></name></person-group><article-title>Interleukin (IL)-15 and IL-7 Jointly Regulate Homeostatic Proliferation of Memory Phenotype CD8+ Cells but Are Not Required for Memory Phenotype CD4+ Cells</article-title><source>J Exp Med</source><year>2002</year><volume>195</volume><issue>12</issue><fpage>1523</fpage><lpage>1532</lpage><pub-id pub-id-type="pmid">12070280</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newell</surname><given-names>EW</given-names></name><name><surname>Sigal</surname><given-names>N</given-names></name><name><surname>Bendall</surname><given-names>SC</given-names></name><name><surname>Nolan</surname><given-names>GP</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name></person-group><article-title>Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes</article-title><source>Immunity</source><year>2012</year><volume>36</volume><issue>1</issue><fpage>142</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">22265676</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>A</given-names></name><name><surname>Andrew</surname><given-names>DP</given-names></name><name><surname>Jablonski-Westrich</surname><given-names>D</given-names></name><name><surname>Holzmann</surname><given-names>B</given-names></name><name><surname>Butcher</surname><given-names>EC</given-names></name></person-group><article-title>Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo</article-title><source>J Immunol</source><year>1994</year><volume>152</volume><issue>7</issue><fpage>3282</fpage><lpage>3293</lpage><pub-id pub-id-type="pmid">7511642</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>BC</given-names></name><name><surname>Martin</surname><given-names>BE</given-names></name><name><surname>Stolberg</surname><given-names>VR</given-names></name><name><surname>Chensue</surname><given-names>SW</given-names></name></person-group><article-title>Cutting edge: Central memory CD8 T cells in aged mice are virtual memory cells</article-title><source>J Immunol</source><year>2013</year><volume>191</volume><issue>12</issue><fpage>5793</fpage><lpage>5796</lpage><pub-id pub-id-type="pmid">24227783</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>MQ</given-names></name><name><surname>Qin</surname><given-names>SX</given-names></name><name><surname>Wu</surname><given-names>LJ</given-names></name><name><surname>Mackay</surname><given-names>CR</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><article-title>Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer&#x02019;s disease brains</article-title><source>Am J Pathol</source><year>1998</year><volume>153</volume><issue>1</issue><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">9665462</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaensson</surname><given-names>E</given-names></name><name><surname>Uronen-Hansson</surname><given-names>H</given-names></name><name><surname>Pabst</surname><given-names>O</given-names></name><name><surname>Eksteen</surname><given-names>B</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Coombes</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans</article-title><source>J Exp Med</source><year>2008</year><volume>205</volume><issue>9</issue><fpage>2139</fpage><lpage>2149</lpage><pub-id pub-id-type="pmid">18710932</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhardt</surname><given-names>T</given-names></name><name><surname>Wakim</surname><given-names>LM</given-names></name><name><surname>Eidsmo</surname><given-names>L</given-names></name><name><surname>Reading</surname><given-names>PC</given-names></name><name><surname>Heath</surname><given-names>WR</given-names></name><name><surname>Carbone</surname><given-names>FR</given-names></name></person-group><article-title>Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus</article-title><source>Nat Immunol</source><year>2009</year><volume>10</volume><issue>5</issue><fpage>524</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">19305395</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tough</surname><given-names>DF</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Sprent</surname><given-names>J</given-names></name></person-group><article-title>An IFN-gamma-dependent pathway controls stimulation of memory phenotype CD8+ T cell turnover in vivo by IL-12, IL-18, and IFN-gamma</article-title><source>Journal of Immunology</source><year>2001</year><volume>166</volume><issue>10</issue><fpage>6007</fpage><lpage>6011</lpage></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>ST</given-names></name><name><surname>Costa</surname><given-names>GL</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Fathman</surname><given-names>CG</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name></person-group><article-title>A novel transcription factor, T-bet, directs Th1 lineage commitment</article-title><source>Cell</source><year>2000</year><volume>100</volume><issue>6</issue><fpage>655</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">10761931</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knox</surname><given-names>JJ</given-names></name><name><surname>Cosma</surname><given-names>GL</given-names></name><name><surname>Betts</surname><given-names>MR</given-names></name><name><surname>McLane</surname><given-names>LM</given-names></name></person-group><article-title>Characterization of T-bet and eomes in peripheral human immune cells</article-title><source>Front Immunol</source><year>2014</year><volume>5</volume><fpage>217</fpage><pub-id pub-id-type="pmid">24860576</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodes</surname><given-names>RJ</given-names></name><name><surname>Hathcock</surname><given-names>KS</given-names></name><name><surname>Weng</surname><given-names>NP</given-names></name></person-group><article-title>Telomeres in T and B cells</article-title><source>NatRevImmunol</source><year>2002</year><volume>2</volume><issue>9</issue><fpage>699</fpage><lpage>706</lpage></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appay</surname><given-names>V</given-names></name><name><surname>Dunbar</surname><given-names>PR</given-names></name><name><surname>Callan</surname><given-names>M</given-names></name><name><surname>Klenerman</surname><given-names>P</given-names></name><name><surname>Gillespie</surname><given-names>GM</given-names></name><name><surname>Papagno</surname><given-names>L</given-names></name><etal/></person-group><article-title>Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections</article-title><source>Nat Med</source><year>2002</year><volume>8</volume><issue>4</issue><fpage>379</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">11927944</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coulie</surname><given-names>PG</given-names></name><name><surname>Brichard</surname><given-names>V</given-names></name><name><surname>Van Pel</surname><given-names>A</given-names></name><name><surname>Wolfel</surname><given-names>T</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Traversari</surname><given-names>C</given-names></name><etal/></person-group><article-title>A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas</article-title><source>J Exp Med</source><year>1994</year><volume>180</volume><issue>1</issue><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">8006593</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messaoudi</surname><given-names>I</given-names></name><name><surname>Guevara Patino</surname><given-names>JA</given-names></name><name><surname>Dyall</surname><given-names>R</given-names></name><name><surname>LeMaoult</surname><given-names>J</given-names></name><name><surname>Nikolich-Zugich</surname><given-names>J</given-names></name></person-group><article-title>Direct link between mhc polymorphism, T-cell avidity and diversity in immune defense</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>1797</fpage><lpage>1801</lpage><pub-id pub-id-type="pmid">12459592</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>JJ</given-names></name><name><surname>Chu</surname><given-names>HH</given-names></name><name><surname>Pepper</surname><given-names>M</given-names></name><name><surname>McSorley</surname><given-names>SJ</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name><name><surname>Kedl</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude</article-title><source>Immunity</source><year>2007</year><volume>27</volume><issue>2</issue><fpage>203</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">17707129</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicin-Sain</surname><given-names>L</given-names></name><name><surname>Messaoudi</surname><given-names>I</given-names></name><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Currier</surname><given-names>N</given-names></name><name><surname>Planer</surname><given-names>S</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><etal/></person-group><article-title>Dramatic increase in naive T cell turnover is linked to loss of naive T cells from old primates</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><issue>50</issue><fpage>19960</fpage><lpage>19965</lpage><pub-id pub-id-type="pmid">18056811</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>D</given-names></name><name><surname>Baars</surname><given-names>PA</given-names></name><name><surname>Rep</surname><given-names>MH</given-names></name><name><surname>Hooibrink</surname><given-names>B</given-names></name><name><surname>Kerkhof-Garde</surname><given-names>SR</given-names></name><name><surname>Klein</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Phenotypic and functional separation of memory and effector human CD8+ T cells</article-title><source>The Journal of Experimental Medicine</source><year>1997</year><volume>186</volume><issue>9</issue><fpage>1407</fpage><lpage>1418</lpage><pub-id pub-id-type="pmid">9348298</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendall</surname><given-names>SC</given-names></name><name><surname>Nolan</surname><given-names>GP</given-names></name><name><surname>Roederer</surname><given-names>M</given-names></name><name><surname>Chattopadhyay</surname><given-names>PK</given-names></name></person-group><article-title>A deep profiler&#x02019;s guide to cytometry</article-title><source>Trends Immunol</source><year>2012</year><volume>33</volume><issue>7</issue><fpage>323</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">22476049</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ornatsky</surname><given-names>O</given-names></name><name><surname>Baranov</surname><given-names>VI</given-names></name><name><surname>Bandura</surname><given-names>DR</given-names></name><name><surname>Tanner</surname><given-names>SD</given-names></name><name><surname>Dick</surname><given-names>J</given-names></name></person-group><article-title>Multiple cellular antigen detection by ICP-MS</article-title><source>J Immunol Methods</source><year>2006</year><volume>308</volume><issue>1&#x02013;2</issue><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">16336974</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenkel</surname><given-names>JM</given-names></name><name><surname>Masopust</surname><given-names>D</given-names></name></person-group><article-title>Tissue-resident memory T cells</article-title><source>Immunity</source><year>2014</year><volume>41</volume><issue>6</issue><fpage>886</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">25526304</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Lugli</surname><given-names>E</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Pos</surname><given-names>Z</given-names></name><name><surname>Paulos</surname><given-names>CM</given-names></name><name><surname>Quigley</surname><given-names>MF</given-names></name><etal/></person-group><article-title>A human memory T cell subset with stem cell-like properties</article-title><source>Nat Med</source><year>2011</year><volume>17</volume><issue>10</issue><fpage>1290</fpage><lpage>1297</lpage><pub-id pub-id-type="pmid">21926977</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haines</surname><given-names>CJ</given-names></name><name><surname>Giffon</surname><given-names>TD</given-names></name><name><surname>Lu</surname><given-names>LS</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>Ross</surname><given-names>DT</given-names></name><etal/></person-group><article-title>Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function</article-title><source>J Exp Med</source><year>2009</year><volume>206</volume><issue>2</issue><fpage>275</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">19171767</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Rabin</surname><given-names>RL</given-names></name><name><surname>Hill</surname><given-names>BJ</given-names></name><name><surname>De Rosa</surname><given-names>SC</given-names></name><name><surname>Perfetto</surname><given-names>SP</given-names></name><name><surname>Zhang</surname><given-names>HH</given-names></name><etal/></person-group><article-title>Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><issue>22</issue><fpage>7916</fpage><lpage>7921</lpage><pub-id pub-id-type="pmid">15905333</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turtle</surname><given-names>CJ</given-names></name><name><surname>Swanson</surname><given-names>HM</given-names></name><name><surname>Fujii</surname><given-names>N</given-names></name><name><surname>Estey</surname><given-names>EH</given-names></name><name><surname>Riddell</surname><given-names>SR</given-names></name></person-group><article-title>A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy</article-title><source>Immunity</source><year>2009</year><volume>31</volume><issue>5</issue><fpage>834</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">19879163</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinrichs</surname><given-names>CS</given-names></name><name><surname>Borman</surname><given-names>ZA</given-names></name><name><surname>Cassard</surname><given-names>L</given-names></name><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Spolski</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><issue>41</issue><fpage>17469</fpage><lpage>17474</lpage><pub-id pub-id-type="pmid">19805141</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanteri</surname><given-names>MC</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name><name><surname>Wen</surname><given-names>L</given-names></name><name><surname>Kaidarova</surname><given-names>Z</given-names></name><name><surname>Bravo</surname><given-names>MD</given-names></name><name><surname>Kiely</surname><given-names>NE</given-names></name><etal/></person-group><article-title>West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety</article-title><source>Transfusion</source><year>2014</year><volume>54</volume><issue>12</issue><fpage>3232</fpage><lpage>3241</lpage><pub-id pub-id-type="pmid">24965017</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betts</surname><given-names>MR</given-names></name><name><surname>Ambrozak</surname><given-names>DR</given-names></name><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>Bonhoeffer</surname><given-names>S</given-names></name><name><surname>Brenchley</surname><given-names>JM</given-names></name><name><surname>Casazza</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection</article-title><source>JVirol</source><year>2001</year><volume>75</volume><issue>24</issue><fpage>11983</fpage><lpage>11991</lpage><pub-id pub-id-type="pmid">11711588</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>P</given-names></name><name><surname>Simonds</surname><given-names>EF</given-names></name><name><surname>Bendall</surname><given-names>SC</given-names></name><name><surname>Gibbs</surname><given-names>KD</given-names><suffix>Jr</suffix></name><name><surname>Bruggner</surname><given-names>RV</given-names></name><name><surname>Linderman</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE</article-title><source>Nature Biotechnology</source><year>2011</year><volume>29</volume><fpage>886</fpage><lpage>891</lpage></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riddell</surname><given-names>NE</given-names></name><name><surname>Griffiths</surname><given-names>SJ</given-names></name><name><surname>Rivino</surname><given-names>L</given-names></name><name><surname>King</surname><given-names>DCB</given-names></name><name><surname>Teo</surname><given-names>GH</given-names></name><name><surname>Henson</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not restricted by telomere-related senescence in young or old adults</article-title><source>Immunology</source><year>2015</year><volume>144</volume><fpage>549</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">25314332</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koshkin</surname><given-names>AA</given-names></name><name><surname>Nielsen</surname><given-names>P</given-names></name><name><surname>Meldgaard</surname><given-names>M</given-names></name><name><surname>Rajwanshi</surname><given-names>VK</given-names></name><name><surname>Singh</surname><given-names>SK</given-names></name><name><surname>Wengel</surname><given-names>J</given-names></name></person-group><article-title>LNA (Locked Nucleic Acid): An RNA Mimic Forming Exceedingly Stable LNA:LNA Duplexes</article-title><source>Journal of the American Chemical Society</source><year>1998</year><volume>120</volume><fpage>13252</fpage><lpage>13253</lpage></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Pertea</surname><given-names>G</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pimentel</surname><given-names>H</given-names></name><name><surname>Kelley</surname><given-names>R</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title><source>Genome Biology</source><year>2013</year><volume>14</volume><fpage>R36</fpage><pub-id pub-id-type="pmid">23618408</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><year>2014</year><volume>15</volume><fpage>550</fpage><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruitt</surname><given-names>KD</given-names></name><name><surname>Harrow</surname><given-names>J</given-names></name><name><surname>Harte</surname><given-names>RA</given-names></name><name><surname>Wallin</surname><given-names>C</given-names></name><name><surname>Diekhans</surname><given-names>M</given-names></name><name><surname>Maglott</surname><given-names>DR</given-names></name><etal/></person-group><article-title>The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes</article-title><source>Genome Research</source><year>2009</year><volume>19</volume><fpage>1316</fpage><lpage>1323</lpage><pub-id pub-id-type="pmid">19498102</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><source>ggplot2: Elegant Graphics for Data Analysis</source><publisher-name>Springer Science &#x00026; Business Media</publisher-name><year>2009</year></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warnes</surname><given-names>GR</given-names></name><name><surname>Bolker</surname><given-names>B</given-names></name><name><surname>Bonebakker</surname><given-names>L</given-names></name><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Liaw</surname><given-names>A</given-names></name><name><surname>LumleyMaechler</surname><given-names>M</given-names></name><name><surname>Magnusson</surname><given-names>A</given-names></name><name><surname>Moeller</surname><given-names>S</given-names></name><name><surname>Schwartz</surname><given-names>M</given-names></name><name><surname>Venables</surname><given-names>B</given-names></name></person-group><source>gplots: Various R Programming Tools for Plotting Data</source><year>2015</year></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Age-related increase in phenotypically naive T cells capable of rapid cytokine production</title><p>(<bold>a</bold>) Intracellular IFN-&#x003b3; staining of human PMA/iono- activated PBMCs from representative healthy adult, 32 y old, and old, 76 y old, donors. Overlaid dot plots show % of naive CD45RA<sup>+</sup>CCR7<sup>+</sup> (yellow gate) and subsequently CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup> (red gate) CD8 T cells producing IFN-&#x003b3;<sup>+</sup> (in blue) overlaid over total CD8<sup>+</sup> T cells (in green). <bold>b.</bold> Percentage of CD8<sup>+</sup> na&#x000ef;ve phenotype CD45<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup> cells producing IFN-&#x003b3; across age. Data are from one of two experiments. t-test was used to show significance in the increase between the group of 21&#x02013;40 years old (n=27); 40 &#x02013; 65 years old (n=44) and 66&#x02013;97 year old donors (&#x0003e;65 years old; n=21; *p&#x0003c;0.05; **p&#x0003c;0.001). <bold>c.</bold> Bar graph showing cytokine production by phenotypically naive CD45RA<sup>+</sup> CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup> CD8<sup>+</sup> T cells from freshly isolated blood (age 32&#x02013;76;n=7).</p></caption><graphic xlink:href="nihms784701f1"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>SPADE analysis of CD8<sup>+</sup> T cells demonstrates clustering of T<sub>MNP</sub> cells with T<sub>N</sub> group</title><p>Two representative subjects (adult, age 27, left; and old, age 68, right) are shown. <bold>a.</bold> IFN-&#x003b3; producing cells form a unique naive CD8<sup>+</sup> T cell subset. Node size depicts the relative count and the color represents IFN-&#x003b3; staining intensity. Four canonical populations are outlined in black, CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>- defined naive population in red, and IFN-&#x003b3;<sup>+</sup> naive population in bright green. <bold>b.</bold> Naive phenotype of IFN-&#x003b3; producing T<sub>MNP</sub> CD8<sup>+</sup>T cells. Colors represent staining intensity of phenotypic markers indicated in the legend. Data are representative of a single experiment (n=9, 6 males, 3 females, age 27&#x02013;78).</p></caption><graphic xlink:href="nihms784701f2"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>T<sub>MNP</sub> cells form a unique T cell subset with naive phenotype that expresses higher levels of CD49d and CXCR3</title><p><bold>a.</bold> Flow cytometry analysis of human PMA/iono-activated PBMCs from a representative donor (age 54). Dot plots show gating strategy used to identify T<sub>MNP</sub> CD8<sup>+</sup> T cells based on the expression of CD45RA<sup>+</sup> CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup> and IFN-&#x003b3; production (four canonical populations are outlined on CCR7 vs CD45RA plot). <bold>b,c.</bold> Overlaid histogram plots show expression level [mean geometric mean fluorescence intensity (gMFI) &#x000b1; standard error of the mean (SEM)] of an indicated surface antigen in different CD8<sup>+</sup> T cell subsets from a representative donor from <bold>a. d.</bold> Repeated measures one-way ANOVA was used to quantify differences in CD49d and CXCR3 expression between T<sub>N</sub> and T<sub>MNP</sub> CD8 T cells (*p&#x0003c;0.01,**P&#x0003c;0.001; data are representative of two experiments, n=13 and 12, age 27&#x02013;85).</p></caption><graphic xlink:href="nihms784701f3"/></fig><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title>T<sub>MNP</sub> cells show signs of prior activation</title><p><bold>a.</bold> CD8<sup>+</sup>T<sub>MNP</sub> cell % after 3h stimulation with indicated agonistic Ab (left) and as a fraction of PMA+iono response (&#x000b1;SD, n=10, 26&#x02013;68y, repeated once). <bold>b.</bold> Intracellular cytokine expression by CD8<sup>+</sup>T cell subsets (n=36, 24&#x02013;82y). <bold>c.</bold> Left, 5% contour plots show representative degranulation (CD107a<sup>+</sup>) and Perforin(Perf) production by IFN-&#x003b3;<sup>+</sup>CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>T<sub>MNP</sub>CD8<sup>+</sup> T cells (black) overlaid over total CD8<sup>+</sup> T cells (gray) (n=2, male, 52,63y of n=8, 31&#x02013;77y, repeated twice). Right, cumulative frequencies of CD107a<sup>+</sup> and Perf<sup>+</sup>CD8<sup>+</sup>T<sub>MNP</sub> cells as percentage of IFN&#x003b3;<sup>+</sup>GzmB<sup>+</sup>T<sub>MNP</sub> (n=8, 31&#x02013;77y; repeated twice). <bold>d.</bold> Day 7 proliferation of sorted CD8<sup>+</sup> T cell subsets in response to 50 ng/mL of IL-7 and IL-15 (subjects as in C; n=4/8 had all memory subsets as controls). <bold>e.</bold> Phenotype changes 3d after cytokine culture in 2 of 3 analyzed subjects (male, 52&#x00026;64y). <bold>f.</bold> Mean gMFI&#x000b1;SEM of T-bet expression in different CD8<sup>+</sup> T cell subsets before or 2h after PMA+iono activation (significance by repeated measures one- way ANOVA between populations, ns= not significant, *p&#x0003c;0.05,**p&#x0003c;0.01, ***p&#x0003c;0.0001, n=9, 6 males, 3 females, age 27&#x02013;78). <bold>g.</bold> Time course of pErk expression (right, gMFI shown) in T<sub>MNP</sub> (CCR7<sup>+</sup>CD45RA<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD49d<sup>hi</sup>) vs T<sub>N</sub> (CCR7<sup>+</sup>CD45RA<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD49d<sup>lo</sup>) CD8<sup>+</sup> T cells following 3h PMA+iono stimulation in a representative 68y old female. Left, mean pErk gMFI &#x000b1;SD (repeated measures one-way ANOVA, n=3, 2 females, 1 male, of n=7, 67&#x02013;83y,*p&#x0003c;0.05; repeated once). <bold>h</bold>. Dose-dependent decrease in IFN-&#x003b3; production by PMA+iono stimulated CD8<sup>+</sup> T cells after pre-incubation with Erk inhibitor (n=14, 5f, 9m, 52&#x02013;83y, repeated once). (Repeated measures one-way ANOVA; *p&#x0003c;0.05, ***p&#x0003c;0.0001).</p></caption><graphic xlink:href="nihms784701f4"/></fig><fig id="F5" orientation="portrait" position="float"><label>Figure 5</label><caption><title>Telomere lengths and RNA transcriptome profile of T<sub>MNP</sub> cells</title><p><bold>a.</bold> Representative FACS plot analysis showing telomere length of different CD8<sup>+</sup> subsets (T<sub>N</sub> (CCR7<sup>+</sup>CD45RA<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup> CD49d<sup>lo</sup>), T<sub>MNP</sub> (CCR7<sup>+</sup>CD45RA<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup> CD49d<sup>hi</sup>)<sub>,</sub> T<sub>CM</sub>, T<sub>E+EM,</sub> T<sub>EMRA</sub>). Numbers indicate gMFI of Cy5 PNA telomere probe staining. Bar graph comparing telomere length of CD8<sup>+</sup> subsets with the length of naive subset within each individual (n=9, 6 females, 3 males, ages 34&#x02013;83). <bold>b.</bold> Plot of the samples projected onto the first two principal components with variables of all Consensus Coding Sequence (CCDS) listed genes that were measured. The color distinguished the cell type (indicated in the figure legend) and shape distinguishes the subject from which the sample was derived. <bold>c.</bold> Heat map of differentially expressed genes (adjP&#x0003c;0.01, FDR&#x0003c;0.05. The expression values for each gene are standardized to a z-score and then binned to a color.</p></caption><graphic xlink:href="nihms784701f5"/></fig><fig id="F6" orientation="portrait" position="float"><label>Figure 6</label><caption><title>T<sub>MNP</sub> cells have skewed TCR V&#x003b2; repertoire and can be detected among T cells responding to stimulation with EBV, CMV, and HIV peptides</title><p><bold>a.</bold> 3D line graphs showing TCR V&#x003b2; distribution in different CD8<sup>+</sup> T cells subsets (T<sub>N</sub> (CD45RA<sup>+</sup> CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>CD49d<sup>lo</sup>), T<sub>MNP</sub> (CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup> CD49d<sup>hi</sup>), T<sub>CM</sub>, T<sub>E+EM</sub> and T<sub>EMRA</sub>) from 3 representative donors (of n=11, 6 males, 5 females, ages 27&#x02013;78) shown as percentages of each of the 24 tested TCR V&#x003b2; (marked on the x axis) are shown. <bold>b,c.</bold> Flow cytometry analysis of PBMCs at 3 h after stimulation with <bold>(b)</bold> EBV BLZF1peptide pool, CMV pp65 peptide pool or IAV matrix protein peptide pool and <bold>(c)</bold> HIV (Gag) peptide pool. Dot plots show gating strategy to evaluate the naive phenotype of the responding (IFN-&#x003b3; producing) CD8<sup>+</sup> T cells. Numbers represent percentages of the population within each gate after subsequent gating (IFN-&#x003b3;<sup>+</sup> CD8<sup>+</sup>T cells followed by CCR7<sup>+</sup>CD45RA<sup>+</sup> gate and subsequently by CD95<sup>lo</sup> CD28<sup>int</sup> gate). Total CD8<sup>+</sup> T cells are shown in gray. <bold>(b)</bold> Data are representative of one healthy donor with an n=8 (3 females, 5 males, ages 34&#x02013;68) for each peptide stimulation; <bold>(c)</bold> Data show the response of three HIV+ ART donors with no detectable HIV in plasma.</p></caption><graphic xlink:href="nihms784701f6"/></fig><fig id="F7" orientation="portrait" position="float"><label>Figure 7</label><caption><title>T<sub>MNP</sub> cells are found among CMV and EBV -specific T cell pools and are not specific for influenza, smallpox, or self-antigens</title><p><bold>a,b.</bold> Flow cytometry analysis of IFN-&#x003b3; production by naive (CD45RA<sup>+</sup>CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>) CMV <bold>(a)</bold> and EBV <bold>(b)</bold> specific CD8<sup>+</sup> T at 3 h after stimulation with PMA+iono. Four representative donors (one CMV seropositive (male, age 72) and one seronegative (female, age 65) and two EBV seropositive (males, ages 67 and 75) (high and low titer) of n=26, ages 28&#x02013;83 (a) or n=7, ages 24&#x02013;75) (b) are shown. Dot plots show gating strategy and the numbers represent percentages of the population within each gate after subsequent gating <bold>c, d.</bold> Flow cytometry analysis of IFN-&#x003b3; production by naive (CCR7<sup>+</sup>CD45RA<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>) vaccinia virus-specific CD8<sup>+</sup> T cells from two representative donors (one CMV seropositive (female, age 64) and one seronegative (female, age 36) (of n=4, ages 36&#x02013;74)) and naive Melan-A-specific CD8<sup>+</sup> T cells from two representative donors, females, ages 58 and 76 (of n=6, ages 29&#x02013;82) after brief stimulation with PMA+iono (same gating strategy was used as in <bold>a, b</bold>). Data are representatives of one (a,b,c) and two (d) experiments.</p></caption><graphic xlink:href="nihms784701f7"/></fig><fig id="F8" orientation="portrait" position="float"><label>Figure 8</label><caption><title>Individuals with symptomatic WNV infection show increased levels of T<sub>MNP</sub> cells</title><p><bold>a,b.</bold> Intracellular IFN-&#x003b3; and GzmB staining of human PMA+iono- activated PBMCs from six representative WNV<sup>+</sup> donors (three WNV asymptomatic (<bold>a</bold>) and three WNV symptomatic (<bold>b</bold>)). Dot plots show gating strategy to quantify T<sub>MNP</sub> (IFN&#x003b3;<sup>+</sup>CD45RA<sup>+</sup> CCR7<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>) CD8<sup>+</sup> T cells (shown as percentages of the population within each gate after subsequent gating and quantified as number (mean &#x000b1;SEM) of T<sub>MNP</sub> cells per million CD8<sup>+</sup> T cells (<bold>c</bold>) (Mann-Whitney test, **p&#x0003c;0.01, n=26). Data are representative of one experiment). <bold>d.</bold> Quantification of T<sub>MNP</sub> CD8<sup>+</sup> T cells (number (mean &#x000b1;SEM) of T<sub>MNP</sub> (IFN&#x003b3;<sup>+</sup>CCR7<sup>+</sup>CD45RA<sup>+</sup>CD95<sup>lo</sup>CD28<sup>int</sup>) cells per million CD8<sup>+</sup> T cells) from individuals with asymptomatic and symptomatic WNV infections early (day 2&#x02013;7) and late (day 60&#x02013;90) after index donation (Repeated measures ANOVA was used to compare symptomatic group to asymptomatic group at two time points. Prior to applying repeated measures, equal variance assumption was tested by Levene&#x02019;s test. The heterogeneous Compound Symmetry covariance structure was used to not only account for the within subject correlation but also adjust for the variance heterogeneity. p=NS, *p&#x0003c;0.05, **p&#x0003c;0.01,(asymptomatic n=11, 39&#x02013;92y old; symptomatic n=16, 43&#x02013;84y). Data are representative of one experiment.</p></caption><graphic xlink:href="nihms784701f8"/></fig></floats-group></article>